GRAIL’s mission is to detect cancer early, when it can be cured. GRAIL has developed Galleri, a breakthrough approach to cancer screening. Galleri is a multi-cancer early detection test that detects more than 50 types of cancer, the majority of which are not commonly screened today, through a routine blood draw. When a cancer is detected, the Galleri test can predict the tissue of origin to help guide next steps to diagnosis.

By partnering with GRAIL, employers can offer a program that can benefit employees by detecting cancer early, when treatment is generally more effective and less costly -- and even when it can be cured.The Galleri test is supported by a comprehensive employee experience and employer program that includes telemedicine services and convenient, nationwide access to labs for testing.